rifapentine
rifapentine: 4 clinical trials tracked.
rifapentine evidence translation
What we can confirm
4 tracked trials
What it means
What to watch
Prepared research question
What is verified about rifapentine, and what remains unknown?
Traceable citations · Unknowns marked
See linked entities and source evidence2 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Clinical Trials (4)
Shortened Regimen for Drug-susceptible TB in Children
Primary endpoint: TB disease-free survival at 48-weeks
Safety and Tolerability of Ultra-short Course Rifapentine and Isoniazid (1HP) for Prevention of Tuberculosis in HIV-Uninfected Individuals
Primary endpoint: Number of Participants Who Complete Treatment With >90% Adherence
Phase I/II Dose Finding and Safety Study of Rifapentine and Isoniazid in HIV-Infected and HIV-Uninfected Children With Latent Tuberculosis Infection
Primary endpoint: Rifapentine Pharmacokinetic Exposure (AUC) Following Weekly 3HP Administration
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Primary endpoint: Participants With Negative Sputum Culture at 8 Weeks